"Dermatologist-Tested" Cosmetics Claim

Issuer

No certifying body issues or approves this claim. In the US it is self-asserted by the manufacturer/brand, subject only to after-the-fact FTC/FDA enforcement if false or misleading. In the EU it is asserted by the 'responsible person' under Reg. (EC) 1223/2009 Art. 4, who must hold substantiating documentation in the product's Product Information File per Reg. 655/2013; no government body pre-reviews or pre-approves the claim before it appears on a label.

Definition

'Dermatologist tested' (also seen as 'dermatologically tested') is a voluntary marketing claim on a cosmetic/personal-care product indicating that a dermatologist, or dermatologists, participated in evaluating the product at some stage - most commonly a skin-tolerance/irritation test on a panel of subjects that a dermatologist conducted or supervised. It is a self-declared advertising statement made by the brand/manufacturer, not a third-party certification, seal, or pass/fail credential.

Guarantees

• That at least one dermatologist was involved, at some point, in testing or reviewing the product - but methodology, sample size, and pass criteria are unspecified and vary by brand.
• (EU only) Per CJEU Case C-99/01, the claim must reflect that the product actually underwent tests studying its skin effects with results showing it was 'well tolerated'; per the 2017 EU Technical Document, brands should hold a summary of the tester's credentials (a board-certified dermatologist is considered appropriate for a skin-benefit claim) and evidence meeting Reg. 655/2013's six criteria (legal compliance, truthfulness, evidential support, honesty, fairness, allowing informed decisions).
• In both the US and EU, if challenged by a regulator or in litigation, the maker must be able to produce 'competent and reliable evidence' behind the claim (FTC substantiation doctrine; EU Product Information File).

Scope level

Product/label-level, self-declared marketing claim - not a certification scheme, not a seal-of-approval program, and not an ingredient- or facility-level standard. Where enforcement occurs, it is case-by-case under general consumer-protection/false-advertising law (FTC Act in the US; Reg. 655/2013 + national unfair-commercial-practices law in the EU), not through a defined certification tier.

Jurisdiction

• United States - FDA (cosmetics labeling) and FTC (advertising substantiation): no regulatory definition of the term exists.
• European Union/EEA - governed by the general framework Regulation (EC) No 1223/2009 plus Commission Regulation (EU) No 655/2013 (common criteria for cosmetic claims), interpreted by CJEU case law (Case C-99/01).
• Other jurisdictions (e.g., Canada, UK, Australia) were not verified in this research pass; treat as not published for this record rather than assumed equivalent to the US or EU.

Change history

• 1975: FDA promulgates a 21 CFR rule attempting to define 'hypoallergenic' - the closest US regulatory precedent for this family of unregulated dermatological-testing claims.
• 1978: U.S. Court of Appeals for the D.C. Circuit invalidates FDA's hypoallergenic definition (Almay-line litigation), after which no federal definition has existed for hypoallergenic- or dermatologist-testing-adjacent claims.
• 24 October 2002: CJEU decides Case C-99/01 (Linhart and Biffl), holding that 'dermatologically tested' implies to the average consumer that skin-effect tests occurred and returned positive, well-tolerated results.
• 10 July 2013 (applied 11 July 2013): EU adopts Commission Regulation (EU) No 655/2013, setting six common criteria that any EU cosmetic claim, including 'dermatologist tested,' must meet.
• 2017 (Annexes III/IV added 3 July 2017): European Commission's Sub-Working Group on Claims issues the non-binding Technical Document on Cosmetic Claims, adding best-practice guidance (e.g., documenting tester credentials) for claims such as 'dermatologist tested.'
• No subsequent binding update has created a specific legal definition, test standard, or registry for this term in the US or EU as of this record's compilation (2026-09-07); absence of change was confirmed, not assumed, in this research pass.

Effective date

• EU Regulation 655/2013: dated 10 July 2013, published OJ L190/31 (11.7.2013), applied from 11 July 2013.
• CJEU Case C-99/01 (Linhart and Biffl): decided 24 October 2002.
• US: no rule specific to this claim ever took effect. The related, invalidated FDA 'hypoallergenic' definition dates to a 1975 rule, struck down in 1978.

Registry lookup

None found. No public database, certificate number, or registry (US or EU) lets a consumer or auditor look up which dermatologist-led testing a specific product underwent, who conducted it, or the results. Brands are not required to disclose this publicly in either jurisdiction, per the FDA and EU regulatory-guidance sources reviewed; this is stated as a confirmed absence, not an unresearched gap.

Standard version

• US: none. No FDA rule defines 'dermatologist tested.' FDA's earlier attempt to formally define the closely related term 'hypoallergenic' via 21 CFR rulemaking (1975) was invalidated by the U.S. Court of Appeals for the D.C. Circuit (1978 Almay-line litigation), leaving no federal definition for either term since.
• EU: Commission Regulation (EU) No 655/2013 'laying down common criteria for the justification of claims used in relation to cosmetic products,' read together with the non-binding 2017 European Commission Technical Document on Cosmetic Claims (Annexes III/IV added 3 July 2017) and CJEU Case C-99/01 (Linhart and Biffl, judgment 24 October 2002), which interprets what 'dermatologically tested' implies to consumers.

Identifier format

Not applicable / not published. No regulator identified in this research issues a standardized certificate ID, license number, or claim code for 'dermatologist tested' statements - unlike true third-party certification marks (e.g., Leaping Bunny, USDA Organic) that do have registries and identifiers.

Does not guarantee

• No guarantee the product won't cause irritation, allergic reaction, or breakouts for any given user.
• No guarantee of hypoallergenic status, non-comedogenicity, or suitability for sensitive/allergic skin - those are separate, similarly unregulated claims.
• No mandated test protocol, minimum panel size, statistical threshold, blinding, or pass/fail cutoff exists in law in either the US or EU for this specific phrase.
• No pre-market government review, certification mark, license number, or registry entry - the claim is not vetted before appearing on a label in either jurisdiction.
• No guarantee that 'dermatologist' means a board-certified dermatologist, or that any testing followed a peer-reviewed methodology, unless the individual brand's non-public substantiation file specifies this.

All research records · Corrections: see our corrections policy.